Syndax(SNDX) - 2020 Q3 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) 35 Gatehouse Drive, Building D, Floor 3 Waltham, Massachusetts 02451 (Address of Principal Executive Offices) (Zip Code) or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 32-0162505 (State or Other Jurisdiction of Incorporation or Organization) For the transition period from to Commission File Number: 001-37708 Syndax Pharmaceuticals, Inc. (Exact Name of Registran ...